0000950170-23-070396.txt : 20231214
0000950170-23-070396.hdr.sgml : 20231214
20231214161512
ACCESSION NUMBER: 0000950170-23-070396
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231212
FILED AS OF DATE: 20231214
DATE AS OF CHANGE: 20231214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: White William Richard
CENTRAL INDEX KEY: 0001778739
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39438
FILM NUMBER: 231487240
MAIL ADDRESS:
STREET 1: C/O AKERO THERAPEUTICS, INC.
STREET 2: 170 HARBOR WAY 2ND FLOOR
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Disc Medicine, Inc.
CENTRAL INDEX KEY: 0001816736
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 851613057
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 321 ARSENAL STREET, SUITE 101
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: (617) 674-9274
MAIL ADDRESS:
STREET 1: 321 ARSENAL STREET, SUITE 101
CITY: WATERTOWN
STATE: MA
ZIP: 02472
FORMER COMPANY:
FORMER CONFORMED NAME: Gemini Therapeutics, Inc. /DE
DATE OF NAME CHANGE: 20210209
FORMER COMPANY:
FORMER CONFORMED NAME: FS Development Corp.
DATE OF NAME CHANGE: 20200702
4
1
ownership.xml
4
X0508
4
2023-12-12
0001816736
Disc Medicine, Inc.
IRON
0001778739
White William Richard
C/O DISC MEDICINE, INC.
321 ARSENAL STREET, SUITE 101
WATERTOWN
MA
02472
true
false
false
false
false
Common Stock
2023-12-12
4
M
false
21084
2.65
A
21084
D
Common Stock
2023-12-12
4
M
false
5427
9.86
A
26511
D
Common Stock
2023-12-12
4
M
false
7000
13.50
A
33511
D
Common Stock
2023-12-12
4
S
false
12100
59.4392
D
21411
D
Common Stock
2023-12-12
4
S
false
1091
63.7324
D
20320
D
Common Stock
2023-12-12
4
S
false
16263
65.2611
D
4057
D
Common Stock
2023-12-12
4
S
false
4057
66.0959
D
0
D
Stock Option (Right to Buy)
2.65
2023-12-12
4
M
false
21084
0.00
D
2030-11-26
Common Stock
21084
7024
D
Stock Option (Right to Buy)
9.86
2023-12-12
4
M
false
5427
0.00
D
2031-09-13
Common Stock
5427
4216
D
Stock Option (Right to Buy)
13.50
2023-12-12
4
M
false
7000
0.00
D
2032-12-28
Common Stock
7000
0
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.00 to $59.6974, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) through (4) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.51 to $63.883, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.995, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.00 to $66.3684, inclusive.
The shares underlying this option vest in 16 equal quarterly installments following November 27, 2020, subject to the Reporting Person's continued service on each such vesting date.
The shares underlying this option vest in 48 equal monthly installments following September 1, 2021, subject to the Reporting Person's continued service on each such vesting date.
The shares underlying this option are fully vested and exercisable as of the date hereof.
By: /s/ Rahul Khara, as Attorney-in-Fact
2023-12-14